Reactive oxygen species and aldehyde dehydrogenase activity in Hodgkin lymphoma cells

Laboratory Investigation

Volumn 92, Issue 4, 2012, Pages 606-614

  Ikeda, Jun Ichiro ^a   Mamat, Suhana ^a,b   Tian, Tian ^a   Wang, Yi ^a   Luo, Wenjuan ^a,c   Rahadiani, Nur ^a   Aozasa, Katsuyuki ^a   Morii, Eiichi ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b INTERNATIONAL ISLAMIC UNIVERSITY MALAYSIA   (Malaysia)

^c MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

aldehyde dehydrogenase; cancer initiating cells; hodgkin lymphoma; reactive oxygen species; tumorigenicity

Indexed keywords

ALDEHYDE DEHYDROGENASE; REACTIVE OXYGEN METABOLITE;

ANIMAL EXPERIMENT; ARTICLE; CANCER CELL; CANCER INITIATING CELL; CELL CYCLE; FEMALE; HODGKIN DISEASE; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOMA CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL;

EID: 84859302354     PISSN: 00236837     EISSN: 15300307     Source Type: Journal    
DOI: 10.1038/labinvest.2012.4     Document Type: Article

References (37)

1. Bonnet D, Dick JE. Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell. Nat Med 1997;3:730-737. (Pubitemid 27298715)
2. Lessard J, Sauvageau G. Bmi-1 determined the proliferative capacity of normal and leukaemic stem cells. Nature 2003;423:255-260. (Pubitemid 40852690)
3. Al-Hajj M, Wicha MS, Benito-Hernandez A, et al. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci USA 2003;100:3983-3988. (Pubitemid 36418143)
4. Singh SK, Hawkins C, Clarke ID, et al. Identification of human brain tumour initiating cells. Nature 2004;432:396-401. (Pubitemid 39551674)
5. Reya T, Morrison SJ, Clarke MF, et al. Stem cells, cancer, and cancer stem cells. Nature 2001;414:105-111. (Pubitemid 33041634)
6. O'Brien CA, Pollett A, Gallinger S, et al. A human colon cancer cell capable of initiating tumor growth in immunodeficient mice. Nature 2007;445:106-110. (Pubitemid 46067310)
7. Ricci-Vitiani L, Lombardi DG, Pilozzi E, et al. Identification and expansion of human colon-cancer-initiating cells. Nature 2007;445:111-115. (Pubitemid 46067311)
8. Kondo T, Setoguchi T, Taga T. Persistence of a small subppulation of cancer stem-like cells in the C6 glioma cell line. Proc Natl Acad Sci USA 2004;101:781-786. (Pubitemid 38121035)
9. Diehn M, Cho RW, Lobo NA, et al. Association of reactive oxygen species levels and radioresistance in cancer stem cells. Nature 2009;458:780-783.
10. Ginestier C, Hur MH, Charafe-Jauffret E, et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007;1:555-567. (Pubitemid 350056407)
11. Chute JP, Muramoto GG, Whitesides J, et al. Inhibition of aldehyde dehydrogenase and retinoid signaling induces the expansion of human hematopoietic stem cells. Proc Natl Acad Sci USA 2006; 103:11707-11712. (Pubitemid 44182515)
12. Liu S, Ginestier C, Charafe-Jauffret E, et al. BRCA1 regulates human mammary stem progenitor cell fate. Proc Natl Acad Sci USA 2008; 105:1680-1685. (Pubitemid 351346574)
13. Ibarra I, Erlich Y, Muthuswamy SK, et al. A role for microRNAs in maintenance of mouse mammary epithelial progenitor cells. Genes Dev 2007;21:3238-3243. (Pubitemid 350277751)
14. Dave B, Chang J. Treatment resistance in stem cells and breast cancer. J Mammary Gland Biol Neoplasia 2009;14:79-82.
15. Jiang F, Qiu Q, Khanna A, et al. Aldehyde dehydrogenase 1 is a tumor stem cell-associated marker in lung cancer. Mol Cancer Res 2009;7:330-338.
16. Matsui W, Wang Q, Barber JP, et al. Clonogenic multiple myeloma progenitors, stem cell properties, and drug resistance. Cancer Res 2008;68:190-197. (Pubitemid 351380120)
17. Pearce DJ, Taussig D, Simpson C, et al. Characterization of cells with a high aldehyde dehydrogenase activity from cord blood and acute myeloid leukemia samples. Stem Cells 2005;23:752-760. (Pubitemid 40791790)
18. Rasheed ZA, Yang J, Wang Q, et al. Prognostic significance of tumorigenic cells with mesenchymal features in pancreatic adenocarcinoma. J Natl Cancer Inst 2010;102:340-351.
19. Su Y, Qiu Q, Zhang X, et al. Aldehyde dehydrogenase 1 A1-positive cell population is enriched in tumor-initiating cells and associated with progression of bladder cancer. Cancer Epidemiol Biomarkers Prev 2010;19:327-337.
20. Li T, Su Y, Mei Y, et al. ALDH1A1 is a marker for malignant prostate stem cells and predictor of prostate cancer patients' outcome. Lab Invest 2010;90:234-244.
21. Kastan MB, Schlaffer E, Russo JE, et al. Direct demonstration of elevated aldehyde dehydrogenase in human hematopoietic progenitor cell. Blood 1990;75:1947-1950.
22. Corti S, Locatelli F, Papadimitriou D, et al. Identification of a primitive brain-derived neural stem cell population based on aldehyde dehydrogenase activity. Stem Cells 2006;24:975-985. (Pubitemid 44464730)
23. Kanzler H, Kuppers R, Hansmann ML, et al. Hodgkin and Reed-Sternberg cells in Hodgkin's disease represent the outgrowth of a dominant tumor clone derived from (crippled) germinal center B cells. J Exp Med 1996;184:1495-1505. (Pubitemid 26354704)
24. Marofioti T, Hummel M, Foss HD, et al. Hodgkin and reed-sternberg cells represent an expansion of single clone originating from a germinal center B-cell with functional immunoglobulin gene rearrangements but defective immunoglobulin transcription. Blood 2000;95:1443-1450. (Pubitemid 30099859)
25. Hsu SM, Zhao X, Chakraborty S, et al. Reed-Sternberg cells in Hodgkin's cell lines HDLM, L-428, and KM-H2 are not actively replicating: lack of bromodeoxyuridine uptake by multinuclear cells in culture. Blood 1988;71:1382-1389.
26. Ikeda J, Mamat S, Tian T, et al. Tumorigenic potential of mono-nucleated small cells of Hodgkin lymphoma cell lines. Am J Pathol 2010;177:3081-3088.
27. Jones RJ, Gocke CD, Kasamon YL, et al. Circulating clonotypic B cells in classic Hodgkin lymphoma. Blood 2009;113:5920-5926.
28. vanDongen JJM, Langerak AW, Bruggemann M, et al. Design and standardization of PCR primers and protocols for detection of clonal immunoglobulin and T-cell receptor gene recombinations in suspect lymphoproliferations: report of the BIOMED-2 concerted action BMH4-CT98-3936. Leukemia 2003;17:2257-2317. (Pubitemid 38072572)
29. Meyer-Siegler KL, Iczknowski KA, Leng L, et al. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells. J Immunol 2006;177:8730-8739. (Pubitemid 44893839)
30. Kurosu T, Fukuda T, Miki T, et al. BCL6 overexpression prevents increase in reactive oxygen species and inhibits apoptosis induced by chemotherapeutic reagents in B-cell lymphoma cells. Oncogene 2003;22:4459-4468. (Pubitemid 36920689)
31. Tothova Z, Kollipara R, Huntly BJ, et al. FoxOs are critical mediators of hematopoietic stem cell resistance to physiologic oxidative stress. Cell 2007;128:325-339. (Pubitemid 46137992)
32. Miyamoto K, Araki KY, Naka K, et al. FoxO3a is essential for maintenance of hematopoietic stem cell pool. Cell Stem Cell 2007;1: 101-112. (Pubitemid 46865800)
33. Guan Y, Gerhard B, Hogge DE. Detection, isolation and stimulation of quiescent primitive leukemic progenitor cells from patients with acute myeloid leukemia (AML). Blood 2003;8:3142-3149. (Pubitemid 36858008)
34. Holyoake T, Jiang X, Eaves C, et al. Isolation of a highly quiescent subpopulation of primitive leukemic cells in chronic myeloid leukemia. Blood 1999;94:2056-2064. (Pubitemid 29430422)
35. Moreb JS, Barker HV, Chang LJ, et al. ALDH isozymes downregulation affects cell growth, cell mobility and gene expression in lung cancer cells. Mol Cancer 2008;7:87.
36. Ma I, Allan AL. The role of human aldehyde dehydrogenase in normal and cancer stem cells. Stem Cell Rev 2011;7:292-306.
37. Rahadiani N, Ikeda H, Mamat S, et al. Expression of aldehyde dehydrogenase 1 (ALDH1) in endometrioid adenocarcinoma and its clinical implications. Cancer Sci 2011;102:903-908.